Founder of Centrexion Therapeutics Corp., Jeffrey B. Kindler is a businessperson who has been the head of 8 different companies and presently occupies the position of Chairman of GLG Healthcare Institute, Executive Chairman for EntityRisk, Inc., Chief Executive Officer & Director at Centrexion Therapeutics Corp., Operating Partner at ARTIS Ventures Management LP and Venture Advisor at Israel Biotech Fund.

He is also Member of The U.S.-Japan Business Council, Inc. and Principal at Paragon Pharmaceuticals Capital LLC and on the board of 10 other companies.

Jeffrey B. Kindler previously occupied the position of Chairman & Chief Executive Officer at Pfizer Inc., Chairman for vTv Therapeutics, Inc., Partner at Williams & Connolly LLP, Director at Starboard Capital Partners LLC, Trustee at The Business Roundtable, Trustee at The Business Council, Editor at The Harvard Law Review Association, Principal at Marathon Pharmaceuticals LLC, Venture Partner at Lux Capital Group LLC, Executive VP-Corporate Relations & General Counsel at McDonald's Corp. and President of Partner Brands (a subsidiary of McDonald's Corp.), Vice President-Litigation & Legal Policy at General Electric Co., Chairman at Boston Market Corp., Chairman of Pharmaceutical Research & Manufacturers of America, Trustee at Ronald McDonald House Charities Central West, Director at Lincoln Center for the Performing Arts, Inc. and Director at Manhattan Theatre Club, Inc.

He received an undergraduate degree from Tufts University and a graduate degree from Harvard Law School.